Agenda

Section II:New Technologies and New Products——Session 3:New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications

2026-03-14 08:30-11:40 Dongyu,Yiyong room(Wanquan Ballroom 1/3)

Moderators:
Supported by:

2026-03-14 08:30-08:50
2026-03-14 08:50-09:10

Regulatory Effects of HMOs on Glucose and Lipid Metabolism Disorders in Adults

Roy attending doctor,Beijing Friendship Hospital,Capital Medical University
2026-03-14 09:10-09:30
2026-03-14 09:30-09:50

The Potential Application Value of HMOs in the Field of Healthy Aging

SHI LEI Professor,West China Hospital,Sichuan University
2026-03-14 09:50-10:10

Research on the Effect of Human Milk Oligosaccharides on Brain Development

Bailiang Li professor,Northeast Agricultural University,vice director
2026-03-14 10:10-10:30

From the Wisdom of Breast Milk to Clinical Promise:HMOs and Probiotics in Synergy to Protect Preterm Infant Gut Health

Hao Shi,CABIO Biotech (Wuhan) Co.,Ltd.Application R&D Lead,Human Nutrition Business Unit
2026-03-14 10:30-10:50

The Effects of Multiple Human Milk Oligosaccharides and HMO-Based Combinations on Infant/Toddler Health and Neurocognitive Development:Evidence-Based Research and Future Innovation Pathways

Cindy Pan,DSM-Firmenich Greater China Science Affairs Director
2026-03-14 10:50-11:10

Unlocking the Health Code of HMOs:Clinical Research Exploration and Practice by Synaura Bio

Fei Yao,Synaura Biotechnology (Shanghai) Co.,Ltd.Head of Application R&D
2026-03-14 11:10-11:30

Global Trends in HMO Research and Applications

Junai Gan,Novonesis, Human Health Biosolutions Scientific Advisor